Synergistic augmentation of expression of plasminogen activator inhibitor type‐1 induced by insulin, very‐low-density lipoproteins, and fatty acids

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Coronary Artery Disease

• Publication date

  1996-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00019501-199611000-00004PMID 8993938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.

  1996cited by this paper
• Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?

  1995cited by this paper
• Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque.

  1994cited by this paper
• Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age.

  1994cited by this paper
• Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients

  1994cited by this paper
• Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina.

  1994cited by this paper
• Levels of plasma thrombomodulin are increased in atheromatous arterial disease.

  1993cited by this paper
• Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1.

  1993cited by this paper
• Insulin Therapy in Type 2 Diabetic Subjects Suppresses Plasminogen Activator Inhibitor (PAI‐1) Activity and Proinsulin‐like Molecules Independently of Glycaemic Control

  1993cited by this paper
• Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.

  1993cited by this paper
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

  1993cited by this paper
• The Relationship Between Plasminogen Activator Inhibitor‐1 and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Mellitus

  1993cited by this paper
• Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty.

  1992cited by this paper
• Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.

  1992cited by this paper
• Hypertriglyceridemia and regulation of fibrinolytic activity.

  1992cited by this paper
• Replication of endothelial cells and smooth muscle cells induced in vivo by hypercholesterolaemia and materials released from platelet‐rich white thrombus

  1992cited by this paper
• Reduction in Factor VII, Fibrinogen and Plasminogen Activator Inhibitor-1 Activity after Surgical Treatment of Morbid Obesity

  1992cited by this paper
• Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial Cells

  1992cited by this paper
• JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells.

  1992cited by this paper
• Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: Implications for vascular disease in hyperinsulinemic states

  1991cited by this paper
• Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro.

  1990cited by this paper
• Effect of central obesity on regulation of carbohydrate metabolism in obese patients with varying degrees of glucose tolerance.

  1990cited by this paper
• 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

  1990cited by this paper
• Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes

  1989cited by this paper
• Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

  1988cited by this paper
• Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2

  1988cited by this paper
• Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with Type 2 (non-insulin-dependent) diabetes

  1987cited by this paper
• Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

  1987cited by this paper
• Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

  1986cited by this paper
• The expected effect of a combination of agents: the general solution.

  1985cited by this paper

• Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers

  2025cites this paper
• The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review.

  2022cites this paper
• A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?

  2021cites this paper
• PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target

  2021cites this paper
• Hemostasis at Extremes of Body Weight

  2018cites this paper
• Diabetes and Heart Disease

  2015cites this paper
• The vulnerable blood. Coagulation and clot structure in diabetes mellitus.

  2015cites this paper
• Hemostatic abnormalities in diabetes mellitus

  2015cites this paper
• The vulnerable blood

  2014cites this paper
• Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome

  2012cites this paper
• PAI-1 and Diabetes: A Journey From the Bench to the Bedside

  2012cites this paper
• Cardiovascular disease and diabetes: the vulnerable patient

  2012cites this paper
• The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance

  2012cites this paper
• Overweight and obesity in hemophilia: a systematic review of the literature.

  2011cites this paper
• Inflammation and thrombosis in diabetes

  2011cites this paper
• Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.

  2011cites this paper
• Type 2 Diabetes and Fibrinolysis

  2011cites this paper
• Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3′-untranslated region of the PAI-1 gene and its pharmacologic implications

  2010cites this paper
• HepG2細胞におけるインスリンと酸化ストレスのPAI-1産生に対する影響の解析: メタボリックシンドロームの易血栓性の病態解明を指向して

  2010cites this paper
• A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart

  2009cites this paper
• Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes

  2009cites this paper
• Role of adipose tissue in haemostasis, coagulation and fibrinolysis

  2009cites this paper
• Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1

  2008cites this paper
• Diabetes mellitus as a prothrombotic condition

  2007cites this paper
• De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome.

  2005cites this paper
• Type 2 diabetes: an atherothrombotic syndrome.

  2005cites this paper
• Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.

  2005cites this paper
• Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance

  2005cites this paper
• Night-time restricted feeding normalises clock genes and Pai-1 gene expression in the db/db mouse liver

  2004influential citation
• Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.

  2004cites this paper
• Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man

  2003cites this paper
• Metabolic Stress and Atherosclerosis

  2003cites this paper
• Polycystic Ovarian Syndrome

  2003cites this paper
• Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis.

  2003cites this paper
• The Independence of Signaling Pathways Mediating Increased Expression of Plasminogen Activator Inhibitor Type 1 in HepG2 Cells Exposed to Free Fatty Acids or Triglycerides

  2002cites this paper
• Plasminogen Activator Inhibitor-1 in Girls with Precocious Pubarche: A Premenarcheal Marker for Polycystic Ovary Syndrome?

  2002cites this paper
• Future Directions: Elucidation of Mechanisms as Targets for Therapy

  2002cites this paper
• Plasminogen Activator Inhibitor‐1: Physiologic Role, Regulation, and the Influence of Common Pharmacologic Agents

  2002cites this paper
• Effect of fatty acid chain length and thioesterification on the augmentation of expression of plasminogen activator inhibitor-1.

  2002cites this paper
• Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids.

  2002cites this paper
• Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in hepG2 cells.

  2001cites this paper
• Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas

  2001cites this paper
• Serum nonesterified fatty acids are related with carotid atherosclerotic plaque in nonobese nonhypertensive Japanese type 2 diabetic patients.

  2001cites this paper
• Diabetes and endothelial dysfunction: a clinical perspective.

  2001cites this paper
• Diabetes mellitus: a hypercoagulable state.

  2001cites this paper
• High prevalence of hypovitaminosis D in female type 2 diabetic population.

  2001cites this paper
• The American Diabetes Association Should Be a Leader in Reducing Medication Errors

  2001cites this paper
• Serum nonesterified fatty acids are increased in nonobese Japanese type 2 diabetic patients with microalbuminuria.

  2001cites this paper
• Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells.

  2000cites this paper
• Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells.

  2000cites this paper
• Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

  2000cites this paper
• AENDO April 41/4

  2000cites this paper
• Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.

  2000cites this paper
• Relationship between fibrinolytic and metabolic variables: a study in patients attending a lipid clinic

  2000cites this paper
• Identification and Localization of a Fatty Acid Response Region in the Human Plasminogen Activator Inhibitor-1 Gene

  2000cites this paper
• Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance

  2000cites this paper
• Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

  2000cites this paper
• Diabetes mellitus induces decreased plasma fibrinolytic activity and increased tissue synthesis of plasminogen activator inhibitor-1 (PAI-1) in the rat

  2000cites this paper
• Protein kinase Cb mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells

  2000cites this paper
• Protein kinase C-β mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells

  2000cites this paper
• The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

  1999cites this paper
• PAI-1, Obesity, and Insulin Resistance

  1999cites this paper
• Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value.

  1999cites this paper
• Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.

  1999cites this paper
• Coronary Artery Disease and Fibrinolysis: From the Blood to the Vessel Wall

  1999cites this paper
• Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche

  1998cites this paper
• Induction of Hyperinsulinemia Combined With Hyperglycemia and Hypertriglyceridemia Increases Plasminogen Activator Inhibitor 1 in Blood in Normal Human Subjects

  1998cites this paper
• Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).

  1998cites this paper
• Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood

  1998cites this paper
• Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

  1998cites this paper
• Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

  1997cites this paper
• The American Diabetes Association Should Be a Leader in Reducing Medication Errors T he

  year unknowncites this paper